A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT01028963
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 159 participants
- Sponsor
- Registry
-
NCT01028963
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Czechia, Germany, Hungary, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT01028963. Randomized; triple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2010-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- pioglitazone
- Intervention (Drug)
- CCX140-B
- Intervention (Drug)
- CCX140-B
- Lead sponsor
- Amgen
Record details
- Record id
cardio:ct-nct01028963- Content hash
a60a479cec42888808c386a7b44bf4c01e7cb67bc3e6e3d0522343b576a44a36